IP Library Granted Patent US 8,663,968
Granted Patent B2
US 8,663,968 · App. 12/600,995 · Granted Mar 4, 2014

Simian T-cell lymphotropic virus

Inventors: William M. Switzer (Stone Mountain, GA); Walid Heneine (Atlanta, GA); Thomas M. Folks (Lithonia, GA); Nathan D. Wolfe (Los Angeles, CA); Donald S. Burke (Pittsburgh, PA); David M. Sintasath (Atlanta, GA)
Assignees: The United States of America as Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention; Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,663,968
App. No.
12/600,995
Granted
Mar 4, 2014
Kind
B2
Abstract

Disclosed are the simian T-cell lymphotropic virus type 3 subtype D (STLV-3 subtype D), isolated nucleic acid molecules encoding STLV-3 subtype D polypeptides, such as STLV-3 subtype D envelope, protease, polymerase, tax, rex, and capsid polypeptides, isolated polypeptides encoded by such nucleic acids. Methods are also disclosed for detecting STLV-3 subtype D, for example by detecting a STLV-3 subtype D nucleic acid or polypeptide in the sample. Accordingly, probes, primers, and antibodies for use in detecting STLV-3 subtype D nucleic acids or polypeptides are disclosed. Therapeutic compositions which included isolated nucleic acid molecules encoding a STLV-3 subtype D polypeptides or isolated polypeptides encoded by such nucleic acid molecules are also disclosed.

Claims (8)

1. An isolated nucleic acid molecule encoding a STLV-3 subtype D (simian T-cell lymphotropic virus type 3 West African subtype D) polypeptide comprising a nucleic acid sequence at least 95% identical to one of: nucleotides 747-2009 of SEQ ID NO: 1; nucleotides 1961-2494 of SEQ ID NO: 1; nucleotides 2416-5061 of SEQ ID NO: 1; nucleotides 5054-6535 of SEQ ID NO: 1; SEQ ID NO: 25; or SEQ ID NO: 26; and a heterologous promoter; wherein the isolated nucleic acid molecule is operably linked to the heterologous promoter.

2. A vector comprising the nucleic acid molecule of claim 1 .

3. An isolated host cell transformed with the vector of claim 2 .

4. The vector of claim 2 , wherein the vector is a viral vector.

5. An isolated viral particle comprising the viral vector of claim 4 .

6. The isolated nucleic acid molecule of claim 1 , wherein the isolated nucleic acid molecule encoding a STLV-3 subtype D (simian T-cell lymphotropic virus type 3 West African subtype D) polypeptide comprises a nucleic acid sequence 100% identical to one of: nucleotides 747-2009 of SEQ ID NO: 1; nucleotides 1961-2494 of SEQ ID NO: 1; nucleotides 2416-5061 of SEQ ID NO: 1; nucleotides 5054-6535 of SEQ ID NO: 1; SEQ ID NO: 25; or SEQ ID NO: 26.

7. The isolated nucleic acid molecule of claim 1 , wherein the isolated nucleic acid molecule encoding a STLV-3 subtype D (simian T-cell lymphotropic virus type 3 West African subtype D) polypeptide consists of a nucleic acid sequence according to one of: nucleotides 747-2009 of SEQ ID NO: 1; nucleotides 1961-2494 of SEQ ID NO: 1; nucleotides 2416-5061 of SEQ ID NO: 1; nucleotides 5054-6535 of SEQ ID NO: 1; SEQ ID NO: 25; or SEQ ID NO: 26.

8. An isolated nucleic acid molecule comprising an isolated STLV-3 subtype D virus comprising a nucleic acid sequence at least 95% identical to SEQ ID NO: 1 and a heterologous promoter, wherein the isolated nucleic acid molecule is operably linked to the heterologous promoter.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 31, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044329/0135 →
Continuity (3)
Provisional Application 60990138 · Nov 26, 2007
Provisional Application 60939304 · May 21, 2007
Related Publication 20100160420A1 · Jun 24, 2010